Evidence map›Paper›PMID 38418089›Full record

ArticleLife science alliance2024

Stable structures or PABP1 loading protects cellular and viral RNAs against ISG20-mediated decay.

Camille Louvat, Séverine Deymier, Xuan-Nhi Nguyen, Emmanuel Labaronne, Kodie Noy, Marie Cariou, Antoine Corbin, Mathieu Mateo, Emiliano P Ricci, Francesca Fiorini and 1 more

Open access · goldAbstract read
In one paragraph

Article in Life science alliance, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Bacterial and human exonucleases mediate interkingdom antiviral immunity.bioRxiv : the preprint server for biology · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Camille LouvatMolecular Microbiology and Structural Biochemistry, MMSB-IBCP, UMR 5086 CNRS University of Lyon, Lyon, France.
Séverine DeymierCentre International de Recherche en Infectiologie(CIRI), Université de Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Nationale Supérieure de Lyon, Lyon, France.
Xuan-Nhi NguyenCentre International de Recherche en Infectiologie(CIRI), Université de Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Nationale Supérieure de Lyon, Lyon, France.
Emmanuel LabaronneLaboratoire de Biologie et Modelisation de la Cellule, Université de Lyon, ENS de Lyon, Université Claude Bernard, CNRS UMR 5239, Inserm, U1293, Lyon, France.ORCID 0000-0001-6314-7809
Kodie NoyCentre International de Recherche en Infectiologie(CIRI), Université de Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Nationale Supérieure de Lyon, Lyon, France.
Marie CariouCentre International de Recherche en Infectiologie(CIRI), Université de Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Nationale Supérieure de Lyon, Lyon, France.ORCID 0000-0002-2544-579X
Antoine CorbinCentre International de Recherche en Infectiologie(CIRI), Université de Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Nationale Supérieure de Lyon, Lyon, France.
Mathieu MateoCentre International de Recherche en Infectiologie(CIRI), Université de Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Nationale Supérieure de Lyon, Lyon, France.
Emiliano P RicciLaboratoire de Biologie et Modelisation de la Cellule, Université de Lyon, ENS de Lyon, Université Claude Bernard, CNRS UMR 5239, Inserm, U1293, Lyon, France.
Francesca FioriniMolecular Microbiology and Structural Biochemistry, MMSB-IBCP, UMR 5086 CNRS University of Lyon, Lyon, France francesca.fiorini@ibcp.fr.ORCID 0000-0001-8388-1576
Andrea CimarelliCentre International de Recherche en Infectiologie(CIRI), Université de Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Nationale Supérieure de Lyon, Lyon, France acimarel@ens-lyon.fr.ORCID 0000-0003-0892-0488
Centre International de Recherche en Infectiologie · FRUniversité Claude Bernard Lyon 1 · FRInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ISG20 is an IFN-induced 3'-5' RNA exonuclease that acts as a broad antiviral factor. At present, the features that expose RNA to ISG20 remain unclear, although recent studies have pointed to the modulatory role of epitranscriptomic modifications in the susceptibility of target RNAs to ISG20. These findings raise the question as to how cellular RNAs, on which these modifications are abundant, cope with ISG20. To obtain an unbiased perspective on this topic, we used RNA-seq and biochemical assays to identify elements that regulate the behavior of RNAs against ISG20. RNA-seq analyses not only indicate a general preservation of the cell transcriptome, but they also highlight a small, but detectable, decrease in the levels of histone mRNAs. Contrarily to all other cellular ones, histone mRNAs are non-polyadenylated and possess a short stem-loop at their 3' end, prompting us to examine the relationship between these features and ISG20 degradation. The results we have obtained indicate that poly(A)-binding protein loading on the RNA 3' tail provides a primal protection against ISG20, easily explaining the overall protection of cellular mRNAs observed by RNA-seq. Terminal stem-loop RNA structures have been associated with ISG20 protection before. Here, we re-examined this question and found that the balance between resistance and susceptibility to ISG20 depends on their thermodynamic stability. These results shed new light on the complex interplay that regulates the susceptibility of different classes of viruses against ISG20.

Indexed as

ExonucleasesExoribonucleasesHistonesRNA, ViralVirus ReplicationExonucleasesExoribonucleasesHistonesRNA, Viral

Identifiers

PMID38418089
PMCPMC10902665
OpenAlexW4392242505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.